Table 1.
All malaria episodes (n=1502) | Plasmodium falciparum mono-infections (n=1237) | Plasmodium malariae mono-infections (n=6) | Plasmodium ovale curtisi mono-infections (n=2) | Plasmodium ovale wallikeri mono-infections (n=1) | Mixed infections (n=183) | No infection*(n=73) | ||
---|---|---|---|---|---|---|---|---|
Sex | ||||||||
Male | 804 (53·5%) | 656 (53·0%) | 4 (66·7%) | 1 (50·0%) | 0 | 107 (58·5%) | 36 (49·3%) | |
Female | 698 (46·5%) | 581 (47·0%) | 2 (33·3%) | 1 (50·0%) | 1 (100%) | 76 (41·5%) | 37 (50·7%) | |
Age, years | 10·0 (5·0–18·0) | 10·0 (5·0–19·0) | 14·5 (5·0–24·0) | 38·5 (15·0–62·0) | 11·0 (11·0–11·0) | 9·0 (6·0–14·0) | 8·0 (5·0–15·0) | |
Age category, years | ||||||||
<5 | 298 (19·8%) | 250 (20·2%) | 1 (16·7%) | 0 | 0 | 29 (15·8%) | 18 (24·7%) | |
5–12 | 634 (42·2%) | 494 (39·9%) | 2 (33·3%) | 0 | 1 (100%) | 103 (56·3%) | 34 (46·6%) | |
>12 to <18 | 179 (11·9%) | 151 (12·2%) | 0 | 1 (50·0%) | 0 | 23 (12·6%) | 4 (5·5%) | |
≥18 | 391 (26·0%) | 342 (27·6%) | 3 (50·0%) | 1 (50·0%) | 0 | 28 (15·3%) | 17 (23·3%) | |
BMI, kg/m2 | 17·4 (4·5) | 17·6 (4·6) | 18·1 (4·1) | 20·2 (3·8) | 26·0 | 16·5 (3·2) | 17·2 (5·0) |
Data are n (%), median (IQR), or mean (SD) for the post-hoc intention-to-treat analysis set. Missing values were not included in the calculation of percentages. There were no patients infected with Plasmodium vivax. BMI=body-mass index.
Assessed by quantitative PCR.